PROVETOP

Biotinylated Cynomolgus GIPR Protein

Catalog No: GIPR-CB001

Species
Cynomolgus
Expression System
HEK293
Tag
His, Avi
Activity
Activity verified

Product overview

Recombinant Biotinylated Cynomolgus GIPR Protein is expressed in HEK293 cells with a His tag and Avi tag at the C-terminus. It contains amino acid residues Gly26-Gln138 (accession: XP_005589662.2).

Product Details

Molecular Aliases
GIP-R; GIPR; PGQTL2
Protein Length
Gly26-Gln138
Expression System
HEK293
Theoretical Molecular Weight
The protein has a predicted MW of 15.91 kDa. Due to glycosylation, the protein migrates to 30-40 kDa based on Bis-Tris PAGE result.
Purity
> 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC
Endotoxin
Less than 1 EU per μg by the LAL method.
Buffer / Formulation
Lyophilized from 0.22 μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
State
Lyophilized
Storage Conditions
-20 to -80°C for 12 months as supplied from date of receipt. -80°C for 3 months after reconstitution. Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
Reconstitution Advice
Dissolve the lyophilized protein in distilled water. Please refer to the Certificate of Analysis for detailed instructions.

Data Display

Bis-Tris PAGE
GIPR-CB001 Bis-Tris-PAGE-white result

Biotinylated Cynomolgus GIPR on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

SEC-HPLC
GIPR-CB001 SEC-HPLC result

The purity of Biotinylated Cynomolgus GIPR is greater than 95% as determined by SEC-HPLC.

ELISA
GIPR-CB001 ELISA result

Immobilized Biotinylated Cynomolgus GIPR, His Avi tag at 0.5μg/ml (100μl/well) on the streptavidin precoated plate (5μg/ml). Dose response curve for Anti-GIPR Antibody, hFc Tag with the EC50 of 8.7ng/ml determined by ELISA. (QC Test)

Background

The gastric inhibitory polypeptide receptor (GIPR), a G protein-coupled receptor (GPCR) that regulates glucose metabolism and insulin secretion, is a target for the development of therapeutic agents to address type 2 diabetes and obesity.

References

  1. Brown KA, Morris RK, Eckhardt SJ, Ge Y, Gellman SH. Phosphorylation Sites of the Gastric Inhibitory Polypeptide Receptor (GIPR) Revealed by Trapped-Ion-Mobility Spectrometry Coupled to Time-of-Flight Mass Spectrometry (TIMS-TOF MS). J Am Chem Soc. 2023 Dec 27;145(51):28030-28037. doi: 10.1021/jacs.3c09078. Epub 2023 Dec 13. PMID: 38091482; PMCID: PMC10842860.

Have questions about this product?

Our technical team can help with product selection, application questions and order support.

Contact Technical Support